FibroGen Misses In First Of Two Pivotal DMD Trials

 
• By Joseph Haas
Shot on goal
Despite miss in DMD, FibroGen has other shots on goal with pamrevlumab • Source: Shutterstock

More from Clinical Trials

More from R&D